Cargando…
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
Despite better therapeutic options and improved survival of diffuse large B-cell lymphoma (DLBCL), 30–40% of the patients experience relapse or have primary refractory disease with a dismal prognosis. To identify biological correlates for treatment resistance, we profiled microRNAs (miRNAs) of match...
Autores principales: | Leivonen, Suvi-Katri, Icay, Katherine, Jäntti, Kirsi, Siren, Ilari, Liu, Chengyu, Alkodsi, Amjad, Cervera, Alejandra, Ludvigsen, Maja, Hamilton-Dutoit, Stephen Jacques, d’Amore, Francesco, Karjalainen-Lindsberg, Marja-Liisa, Delabie, Jan, Holte, Harald, Lehtonen, Rainer, Hautaniemi, Sampsa, Leppä, Sirpa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802506/ https://www.ncbi.nlm.nih.gov/pubmed/29242506 http://dx.doi.org/10.1038/s41408-017-0033-8 |
Ejemplares similares
-
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017) -
Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment
por: Autio, Matias, et al.
Publicado: (2022) -
T026: Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2022) -
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021) -
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2020)